VENTAS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.5 USD | +0.66% |
|
-2.88% | -4.70% |
| May. 20 | BMO Capital Adjusts Ventas Price Target to $53 From $51 | MT |
| May. 16 | Scotiabank Adjusts Price Target on Ventas to $51 From $47 | MT |
Financials (USD)
| Sales 2024 * | 4.83B | Sales 2025 * | 5.1B | Capitalization | 19.19B |
|---|---|---|---|---|---|
| Net income 2024 * | -74M | Net income 2025 * | -14M | EV / Sales 2024 * | 6.64 x |
| Net Debt 2024 * | 12.87B | Net Debt 2025 * | 13B | EV / Sales 2025 * | 6.31 x |
| P/E ratio 2024 * |
-213
x | P/E ratio 2025 * |
3,139
x | Employees | 486 |
| Yield 2024 * |
3.8% | Yield 2025 * |
4.02% | Free-Float | 99.39% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ventas, Inc.
More recommendations
More press releases
More news
| 1 day | +0.66% | ||
| 1 week | -2.88% | ||
| Current month | +7.27% | ||
| 1 month | +7.95% | ||
| 3 months | +10.54% | ||
| 6 months | +5.30% | ||
| Current year | -4.70% |
1 week
47.17
48.98
1 month
43.6449.10
Current year
41.4550.61
1 year
39.3350.99
3 years
35.3364.02
5 years
13.3575.40
10 years
13.3581.93
| Managers | Title | Age | Since |
|---|---|---|---|
Debra Cafaro
CEO | Chief Executive Officer | 66 | 98-12-31 |
Bob Probst
DFI | Director of Finance/CFO | 56 | 14-10-26 |
| Chief Tech/Sci/R&D Officer | - | 19-01-24 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Embler
BRD | Director/Board Member | 60 | 22-03-06 |
Matthew Lustig
BRD | Director/Board Member | 63 | 11-05-11 |
Marguerite Nader
BRD | Director/Board Member | 55 | 20-07-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.03% | 197 M€ | -.--% | ||
| 1.91% | 258 M€ | -3.91% | ||
| 1.43% | 133 M€ | +4.99% | ||
| 0.99% | 0 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-24 | 47.5 | +0.66% | 1,056,420 |
| 24-05-23 | 47.19 | -2.64% | 1,658,030 |
| 24-05-22 | 48.47 | +0.21% | 1,527,674 |
| 24-05-21 | 48.37 | -0.74% | 1,309,408 |
Delayed Quote Nyse, May 24, 2024 at 04:00 pm EDT
More quotes
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities.
At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13).
Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).
Sector
Specialized REITs
Calendar
2024-06-30
- Ex-dividend day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
47.5
USD
Average target price
53.5
USD
Spread / Average Target
+12.63%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.70% | 19.19B | |
| +11.87% | 60.31B | |
| -3.54% | 13.44B | |
| +2.64% | 7.78B | |
| -9.17% | 5.92B | |
| +13.40% | 3.61B | |
| +1.05% | 3.34B | |
| -6.52% | 3.06B | |
| +2.65% | 3.03B | |
| +16.33% | 2.82B |
- Stock Market
- Equities
- VTR Stock
